SAAM

Welcome to the Brand page for “SAAM”, which is offered here for Medical diagnostic test kits for diagnostic medical use primarily comprised of test strips utilizing the amplification of dna or rna for measuring analytes in solution in order to facilitate the detection of infectious pathogens that commonly cause upper and lower respiratory diseases, legionella, streptococcus pneumoniae, influenza a, influenza b, respiratory syncytial virus, adenovirus, parainfluenza, non-typable haemophilus influenzae, moraxella catarrhalis, neisseria meningitidis, pseudomonas aeruginosa, staphylococcus aureus, mycobacterium tuberculosis, methicillin resistant staphylococcus aureus, sars, human metapneumovirus, chlamydia pneumoniae, mycoplasma pneumoniae and other infectious disease agents, malaria pf/pv, filariasis, hepatitis hbsag and age, dengue virus, and other analytes;saam;diagnostic test kits for research use primarily comprised of chemicals and reagents utilizing the amplification of dna or rna for measuring analytes in solution in order to facilitate the detection of infectious pathogens that commonly cause upper and lower respiratory diseases, legionella, streptococcus pneumoniae, influenza a, influenza b, respiratory syncytial virus, adenovirus, parainfluenza, non-typable haemophilus influenzae, moraxella catarrhalis, neisseria meningitidis, pseudomonas aeruginosa, staphylococcus aureus, mycobacterium tuberculosis, methicillin resistant staphylococcus aureus, sars, human metapneumovirus, chlamydia pneumoniae, mycoplasma pneumoniae and other infectious disease agents, malaria pf/pv, filariasis, hepatitis hbsag and age, dengue virus, and other analytes;.

Its status is currently believed to be active. Its class is unavailable. “SAAM” is believed to be currently owned by “BINAX, INC.”